{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T17:11:50Z","timestamp":1721668310105},"reference-count":24,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T00:00:00Z","timestamp":1182988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[2007,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Results of recent studies suggest that human chorionic gonadotropin (HCG), a placental glycoprotein hormone required for the maintenance of pregnancy, may have immunomodulatory properties. Primary Sj\u00f6gren's syndrome (SS), a chronic autoimmune disorder of unknown etiology, affects multiple exocrine glands including the salivary and lacrimal glands. The purpose of the present study was to determine whether HCG could prevent the development of salivary gland exocrinopathy in NOD mice, an experimental model of Sj\u00f6gren's\u2010like syndrome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Female NOD mice were treated with HCG from 6 weeks of age to 12 weeks of age. At 14 weeks, tissue samples were evaluated for inflammatory lesions and cytokine messenger RNA by real\u2010time polymerase chain reaction. At 18 weeks, the salivary flow rate was measured.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Treatment with HCG resulted in a significant decrease in lymphocyte infiltration and parenchymal cell damage in the submandibular salivary glands. Messenger RNA levels of interferon\u2010\u03b3, tumor necrosis factor \u03b1, interleukin\u20101\u03b2, and interleukin\u201010, as well as inducible nitric oxide synthase and matrix metalloproteinase 9, were significantly decreased. Function studies revealed a marked increase in the salivary flow rate in HCG\u2010treated mice compared with that in phosphate buffered saline\u2013treated mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In NOD mice, HCG acts as an immune modulator and prevents the development of salivary gland exocrinopathy. These findings suggest that HCG, a naturally occurring reproductive hormone, may be useful in the treatment of Sj\u00f6gren's syndrome and other human autoimmune diseases.<\/jats:p><\/jats:sec>","DOI":"10.1002\/art.22737","type":"journal-article","created":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T17:46:49Z","timestamp":1183052809000},"page":"2211-2215","source":"Crossref","is-referenced-by-count":9,"title":["Human chorionic gonadotropin prevents Sj\u00f6gren's syndrome\u2013like exocrinopathy in mice"],"prefix":"10.1002","volume":"56","author":[{"given":"Na","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshikatsu","family":"Shigihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios G.","family":"Tzioufas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abner L.","family":"Notkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji\u2010Won","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee\u2010Sook","family":"Jun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,6,28]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-4857-7_18"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/154411130201300103"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni0901-777"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.10.5369"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.23.2.0462"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.5.2305"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200009)43:9<2064::AID-ANR18>3.0.CO;2-Z"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(01)00368-8"},{"issue":"2","key":"e_1_2_7_10_2","first-page":"A260","article-title":"Human choriogonadotropin can prevent autoimmune diabetes in NOD mice","volume":"50","author":"Jun HS","year":"2001","journal-title":"Diabetes"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65027-4"},{"key":"e_1_2_7_12_2","first-page":"365","article-title":"Primer3 on the WWW for general users and for biologist programmers","volume":"132","author":"Rozen S","year":"2000","journal-title":"Methods Mol Biol"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21265"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(01)00654-2"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2005.02.033"},{"key":"e_1_2_7_17_2","first-page":"159","article-title":"Effects of human chorionic gonadotropin (hCG) and \u03b2\u2010hCG on oncostatin M release from human peripheral blood mononuclear cells in vitro","volume":"92","author":"Komorowski J","year":"1997","journal-title":"Cytobios"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-13906"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.21.2751"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610243351702"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.143.8.3114"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.22.11710-11714.2002"},{"key":"e_1_2_7_23_2","first-page":"841","article-title":"Testicular function in active ankylosing spondylitis: therapeutic response to human chorionic gonadotrophin","volume":"18","author":"Tapia\u2010Serrano R","year":"1991","journal-title":"J Rheumatol"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.18.13307"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M400683200"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.22737","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.22737","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T04:05:56Z","timestamp":1698725156000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.22737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,28]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["10.1002\/art.22737"],"URL":"https:\/\/doi.org\/10.1002\/art.22737","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,28]]}}}